Kennedy, PhD


Giulia C. Kennedy, Ph.D. is a prolific scientific leader with over 20 years’ experience in molecular diagnostics, genomics and commercialization of products in the life sciences industry. She was most recently the Chief Scientific and Chief Medical Officer at Veracyte, and as part of the founding team, led the research, clinical development and launch of 6 diagnostic tests that achieved payor reimbursement and have changed the standard of care for patients with cancer and other disease. Previously, Dr. Kennedy led scientific research and development teams at Millennium Pharmaceuticals, Chiron Corporation and Affymetrix. Dr. Kennedy is a member of the Steering Committee for the Cancer Evolution working group of the American Association of Cancer Research, an advisor to the UCSF Catalyst program, and is a Board director for Astarte Medical, Inc. and Acuamark, Inc. She earned her doctorate degree from Case Western Reserve University and lives in San Francisco, CA.